SEOUL, South Korea--(BUSINESS WIRE)--Hemohim is garnering remarkable popularity in the global market as Korea's one of the leading functional foods. Hemohim is developed through an eight-year ...
SEOUL, South Korea, July 24, 2024--(BUSINESS WIRE)--Kolmar BNH (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion ...
SEOUL, South Korea--(BUSINESS WIRE)--‘HemoHim,’ an immune-boosting health supplement from Kolmar BNH (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and ...
KUALA LUMPUR, April 22 (Bernama) -- Hemohim developed via an eight-year collaboration between Kolmar BNH and the Korea Atomic Energy Research Institute, is garnering remarkable popularity in the ...
SEOUL, South Korea — Kolmar BNH (KRX: 200130), a prominent Korean health functional food Original Development Manufacturing (ODM) firm, announced that it has unveiled its latest offering, HemoHIM G, ...
HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy, contains Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora. It was launched in Taiwan last month. (Photo: Kolmar BNH) ...
Hemohim is developed through an eight-year collaboration between Kolmar BNH (KOSDAQ: 200130) and the Korea Atomic Energy Research Institute, with an investment of KRW 5 billion. It was extracted from ...
HemoHIM G represents an enhanced iteration of HemoHIM, tailored to meet the distinctive tastes of consumers in Taiwan and Europe. Kolmar BNH plans to expedite its market expansion in Asia by launching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback